Skip to content

MDMA: all studies

Page 260 of 345: studies 2,591 to 2,600 of 3,446, newest first. Back to the MDMA overview

Research

Review of Selected 2-Phenylethylamine Derivatives and Opioids, Systematic Review of Their Effects on Psychomotor Abilities and Driving Performance: Psychopharmacology in the Context of Road Safety

Pharmaceuticals October 28, 2025 Kacper Żełabowski, Kamil Biedka, Wojciech Pichowicz et al.

Background: Driving is a coordinated psychomotor activity that involves reaction time, attention, and decision-making. Psychoactive substances such as 2-phenylethylamine (PEA) derivatives and opioids may affect these functions and contribute to traffic safety. This systematic review revealed the effects of the selected PEA derivatives and opioids on psychomotor performance among drivers and...

DOI: 10.3390/ph18101555 (opens in new tab) Full text (opens in new tab) Psychopharmacotherapy Drug abuse Psychoactive substances Psychomotor performance +2

Drug-centered or drug-assisted? Epistemic perspectives and methodological tensions in psychedelic psychotherapy

European Journal for Philosophy of Science October 25, 2025 Karen Yan, Chao Ni, Yun-Ying Kuo et al.

Abstract This paper distinguishes the drug-centered view of psychedelics (DCP) and the drug-assisted view of psychedelics (DAP). While these approaches differ conceptually, both rely on the methodology of evidence-based medicine, using randomized controlled trials to validate therapeutic efficacy. Using MDMA-assisted psychotherapy as a case study of DAP, we reconstruct the causal reasoning...

DOI: 10.1007/s13194-025-00679-9 (opens in new tab) Full text (opens in new tab) Philosophy of science Key lock Cognition Causality physics +3

Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.

Progress in Neuro-Psychopharmacology and Biological Psychiatry October 20, 2025 Arthur L. De Oliveira, Danielle P. De Oliveira, Rafael G. Dos Santos et al.

Psychedelics are mind-altering substances that have shown promising effects in the treatment of neuropsychiatric disorders owing to their antidepressant, anxiolytic and antiaddictive effects. However, data on their developmental toxicity is scarce, which might hinder its therapeutic suitability, and preclinical data on their behavioral effects is mainly restricted to rodents. In this context,...

DOI: 10.1016/j.pnpbp.2025.111534 (opens in new tab) Zebrafish Psychedelics Behavior Development +1

"Chemical Seduction": a narrative review of the complex impact of recreational drugs on sexual function.

International journal of impotence research October 17, 2025 Nir Meller, Noam Kitrey

Humans have long used various substances to enhance sexual pleasure and performance, often at the expense of their overall health. This review investigates the sexual-related effects of recreational drugs, including amphetamines, 3,4-methylenedioxymethamphetamine (MDMA), mephedrone, gamma-hydroxybutyrate (GHB), and ketamine. By examining anecdotal evidence, self-reports, and limited scientific...

Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment

Psychedelics October 14, 2025 Sha Jin, H.y. Wang, Xiaohui Wang

Psychiatric illness, particularly stress-related disorders including depression, anxiety and posttraumatic stress disorder, presents a considerable health burden worldwide with high prevalence, disabling symptoms, and scant efficacy of available treatments. Chronic stress is a major contributor to the origin and development of these conditions, to the detriment of both individual and, by...

DOI: 10.61373/pp025v.0038 (opens in new tab) Anxiety Context archaeology Mental health Perspective graphical +8

Psychedelics in Practice: Science, Safety, and the Future of Healing

PROCEEDINGS OF THE SLIIT INTERNATIONAL CONFERENCE ON ADVANCEMENTS IN SCIENCES AND HUMANITIES [SICASH] October 10, 2025 Renee Ireland

Psychedelic-assisted therapies are re-emerging as credible options in psychological care amid a high global burden of mental ill-health and limited response to first-line treatments. Once marginal, psychedelics are now part of mainstream research and policy debate, while remaining illegal or tightly restricted in many jurisdictions. Classic and atypical compounds (e.g., psilocybin, MDMA) act...

Psychedelika assistierte Therapie

Psychotherapie-Wissenschaft October 1, 2025 Heiner Dörfler

Die psychedelika assistierte Psychotherapie erfährt aktuell eine wissenschaftlich fundierte Renaissance. Studien zeigen eine therapeutische Wirksamkeit von Substanzen wie Psilocybin, LSD und MDMA bei verschiedenen psychischen Störungsbildern, insbesondere bei therapieresistenter Depression, PTBS, Angstund Suchterkrankungen. In der Schweiz nimmt diese Entwicklung eine besondere Stellung ein: Als...

DOI: 10.30820/1664-9583-2025-2-7 (opens in new tab) Chronic disease Butyrophenone Continuing education Gynecology

Preparing Social Work for Psychedelic-Assisted Therapy.

Social Work October 1, 2025 Heidi L Allen, Brooke L Stott

With MDMA, LSD, and psilocybin receiving “Breakthrough Therapy” designation by the U.S. Food and Drug Administration (FDA) and moving into Phase 3 clinical trials, we are closer than ever to legal administration of these compounds for mental health treatment. Research from Lykos, Usona Institute, Mindmed, Compass Pathways, and Johns Hopkins, among others, has shown promising efficacy of the...

Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction

Progress in Neuro-Psychopharmacology and Biological Psychiatry October 1, 2025 Marta L.c. Palhas, Rémi Corne, Raymond Mongeau 4 citations

After years of restrictions due to concerns about their potentially harmful effects, research on psychedelics has entered a new era. Increasing attention has been directed toward their immense therapeutic potential, particularly for psychiatric disorders. Pre-clinical and clinical studies have consistently demonstrated that psychedelic treatments produce therapeutic effects within hours of...

María Sabina's Prayer

September 18, 2025 Herlinda Flores Badillo

María Sabina became well known around the world for her great shamanic power and because people were intrigued by her and her relationship with hallucinogenic mushrooms, or niños santos (saint children), as she called them. The present chapter analyzes María Sabina’s prayers/chants – nijmi – in her mother tongue, Mazatec. Their anaphoric structure, commonly used by poets of this tradition, was...